Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000102909-25-000328·Tonix Pharmaceuticals Holding Corp.
Schedule 13G ownership disclosure
Tonix Pharmaceuticals Holding Corp
Common Stock · CUSIP: 890260839
Event date: 2025-09-30
- Filing-level shares
- 556,957
- Percent of class
- 6.35%
- The Vanguard Group
Shares: 556,957 · Class: 6.35%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000328
- Form type
- SCHEDULE 13G
- Filer
- Tonix Pharmaceuticals Holding Corp.
- CIK
- CIK 1430306
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership